QUIDEL ADENO PLUS TEST
Acute Conjunctivitis - more commonly known as "pink eye" - affects nearly 6.9 million people in the United States every year. Approximately 1 in 4 patients with acute conjunctivitis have confirmed adenoviral conjunctivitis. AdenoPlus is in the first and only CLIA-Waived, point-of-care test that detects all known serotupes of Adenoviral Conjunctivitis. Early and accurate diagnosis of pink eye may prevent serious consequences including morbidity. Significant overlap exists in the clinical signs and symptoms of acute conjuctivitis and misdiagnosis by eye care professionals occurs in approximately 50% of conjuctivitis cases with AdenoPlus you can make a rapid, accurate diagnosis before the patient leaves the office.